Stocks
Estrella Immunopharma, Inc.ESLA
NASDAQHealthcareBiotechnology$0.73
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, with a focus on CAR T-cell and other cell-based treatments. Its pipeline includes investigational products aimed at solid tumors, and investors track it for potential regulatory milestones and clinical trial updates.
52W Range: $0.24-$3.15
Congressional Interest in Estrella Immunopharma, Inc. (ESLA)
No congressional trades have been disclosed for Estrella Immunopharma, Inc. (ESLA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ESLA?
No congressional trades found for this stock.